Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-10-01FDA Approved: SEYSARA — Original Application (Almirall, LLC)
The FDA approved SEYSARA (sarecycline hydrochloride) from Almirall, LLC under an Original New Drug Application, for the treatment of acne vu…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Efficacy Study in Patients With Acne Vulgaris. [Phase 2]
Phase 2 clinical trial assessing efficacy in acne vulgaris has completed and results posted.
-
FDA approval · 2018-08-31FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for AMNESTEEM (isotretinoin) submitted by Mylan Pharmaceuticals. This action approves changes to…
-
FDA approval · 2018-08-31FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc. to update the labeling.
-
FDA approval · 2018-08-31FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved Mayne Pharma's supplemental application for isotretinoin.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-08-31FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for ZENATANE (isotretinoin) filed by BluePoint Laboratories, approving changes to the existing label…
-
FDA approval · 2018-08-31FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approves a supplemental application for isotretinoin filed by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2018-08-31FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc.
-
FDA label_change · 2018-08-31FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, resulting in an update to th…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris [NA]
A completed clinical trial evaluating tolerance of an acne treatment in sensitive skin with mild to moderate acne vulgaris; results posted i…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial comparing tazarotene 0.1% cream to a comparator and placebo in acne vulgaris completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia [Phase 4]
Phase 4 trial reported on the efficacy and tolerability of nicotinamide plus cream for moderate acne vulgaris in Indonesia.
-
CLINICAL_TRIALS research · 2018-07-31Clinical Trial Update: Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ]
This clinical trial update from Assiut University examines the relationship between thyroid dysfunction and acne vulgaris in female patients…
-
CLINICAL_TRIALS withdrawal · 2018-07-26Clinical Trial Update: Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT [NA]
A clinical trial evaluating the use of an Er:YAG laser for treating acne scars in patients with acne vulgaris was withdrawn before completio…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream [Phase 1]
A Phase 1 trial evaluating the absorption and systemic pharmacokinetics of IDP-123 Lotion compared with Tazorac Cream in acne; the study has…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Low Glycemic Index and Load Diet for the Treatment of Acne [NA]
A completed clinical trial assessed whether a low glycemic index and load diet can treat acne vulgaris through diet modification.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris [NA]
This clinical trial update notes the completed study examining teledermatology and modulation of antibiotic dosing for acne vulgaris.
-
FDA approval · 2018-06-05FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic clindamycin phosphate and benzoyl peroxide topical product for acne vulgaris.
-
FDA approval · 2018-06-01FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic clindamycin phosphate and benzoyl peroxide topical product, expanding access for a…
-
FDA approval · 2018-05-25FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic clindamycin phosphate and benzoyl peroxide gel for acne vulgaris (original application).
-
FDA approval · 2018-05-23FDA Approved: ADAPALENE AND BENZOYL PEROXIDE GEL, 0.1%/2.5% — Original Application (Encube Ethicals, Inc.)
FDA approved Encube Ethicals' adapalene 0.1%/benzoyl peroxide 2.5% gel as an original ANDA product for acne vulgaris.
-
FDA approval · 2018-05-18FDA Approved: ACZONE — Supplemental Application (Almirall, LLC)
The FDA approved a supplemental application for ACZONE (dapsone) submitted by Almirall, LLC.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris [EARLY_Phase 1]
This clinical trial update evaluates the therapeutic equivalence and safety of Tretinoin Cream 0.1% versus the reference listed drug for acn…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris [EARLY_Phase 1]
An early Phase 1 trial evaluating therapeutic equivalence and safety of tretinoin cream 0.05% versus the reference listed drug in acne vulga…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris [Phase 1]
This completed Phase 1 trial compared a clindamycin and benzoyl peroxide combination gel (1.2%/3.75%) to Onexton Gel for treating acne vulga…